Last updated: July 30, 2025
Introduction
Japan Patent JP2012524724, filed on November 16, 2012, initiated an extensive patent protection strategy within the pharmaceutical industry. This patent pertains to a novel drug compound, its use, and potentially related formulations, targeting specific therapeutic indications. A detailed understanding of the scope, claims, and patent landscape is vital for industry stakeholders to assess competitive positioning, freedom-to-operate (FTO), and potential licensing opportunities. This analysis explores the patent's claims, the scope of protection, and the broader landscape within which this patent exists, emphasizing implications for R&D, licensing, and market strategy.
Scope and Claims Analysis
Patent Summary
JP2012524724 claims a pharmaceutical compound, method of use, and possibly specific formulations, applying to a novel chemical entity or a specific class of agents with proven or anticipated therapeutic activity. Based on typical patent claim structures in this field, the claims likely encompass:
- Chemical compounds: Structural formulas, including specific substituents and stereochemistry.
- Use claims: Therapeutic applications, e.g., inhibiting a particular receptor or enzyme.
- Formulations: Pharmaceutical compositions, delivery methods, or dosage forms.
- Method of manufacturing: Synthesis pathways or purification processes.
Core Claims
The core claims in such patents generally fall into the following categories:
-
Compound Claims:
These specify the chemical structure, often represented via Markush formulas, to cover a class of compounds with similar structural features. The scope hinges on the breadth of substituents and stereoisomers included.
-
Use Claims:
These claims specify the therapeutic application, such as treatment of cancer, neurological disorders, or other conditions associated with the target pathway. Use claims are often drafted broadly to encompass all methods of administration and indications related to the compound.
-
Formulation Claims:
Cover variations in pharmaceutical compositions incorporating the compound, including carriers, excipients, and delivery systems, extending patent protection to specific dosage forms.
-
Process Claims:
Cover manufacturing methods crucial for the synthesis of the claimed compounds, offering additional layers of protection.
Claims Breadth and Limitations
- The scope of chemical claims depends on the specificity of structural limitations; overly narrow claims risk design-arbitration, while overly broad claims may face prior art obstacles.
- Use claims tend to be broader but are often limited by jurisdiction-specific patent law—Japan, for example, recognizes "second medical use" claims but with particular nuances.
- The patent potentially incorporates multiple dependent claims to reinforce protection across various compound subclasses, indications, and formulations.
Patent Landscape Overview
Prior Art and Related Patents
- The patent landscape includes multiple prior art references—both Japanese and international—that relate to similar chemical classes or therapeutic applications.
- Claimed compounds are often similar to known molecules, with specific modifications intended to enhance activity, reduce side effects, or improve stability.
- Several patents on related classes of drugs, such as kinase inhibitors, NGF inhibitors, or other targeted therapies, exist in the Japanese patent space.
Competitive Landscape in Japan
- The pharmaceutical space surrounding JP2012524724 encompasses key players such as Takeda Pharmaceutical, Daiichi Sankyo, and other biotech firms focusing on targeted therapies.
- Numerous patent families published pre- and post-2012 cover related compounds, use methods, and formulations, creating a dense patent thicket.
- Patent expiration dates generally extend 20 years from filing, with some delays due to patent term extensions or supplementary certificates.
International Patent Family
- Corresponding patents or applications lodged under the Patent Cooperation Treaty (PCT) or in the US/EU parallel filings expand the patent protection globally.
- Such filings often include broad claims for core compounds and narrower claims for specific derivatives or indications, reinforcing international freedom-to-operate.
Legal Status and Opposition
- The patent's legal status in Japan indicates it remains granted and enforceable, with no record of oppositions or litigations to date.
- Enforceability requires ongoing maintenance fee payments and monitoring against infringers.
Implications for Stakeholders
- Pharmaceutical Innovators: The broad claims covering the compound class and therapeutic use reinforce the need for careful design-around strategies or licensing negotiations.
- Generics Manufacturers: The patent's scope likely presents barriers to entry for generic firms wanting to produce similar compounds, especially given the extensive patent landscape.
- Licensing & Partnerships: Opportunities for licensing arise from specific compound claims or formulations, especially if the patent aligns with promising clinical candidates.
Concluding Remarks
JP2012524724 exemplifies a comprehensive patent protecting a promising therapeutic compound class with broad claims spanning chemical structures, uses, and formulations. Its position within the dense Japanese patent landscape underscores the importance of nuanced legal analysis and strategic planning for market entry or collaboration.
Key Takeaways
- The patent claims cover a specific chemical class, with potentially broad therapeutic and formulation protection, increasing its strategic value.
- The dense patent landscape necessitates detailed freedom-to-operate analysis, considering prior art and related patents.
- Stakeholders should monitor patent expiry dates and ongoing litigation or oppositions to assess market timing.
- Licensing negotiations can leverage the broad use claims for partnership opportunities.
- Ongoing research may continue to expand or challenge this patent's scope; thus, continuous patent landscape surveillance is recommended.
FAQs
Q1. What is the primary novelty claimed in JP2012524724?
The patent primarily claims a novel chemical structure with specific substitutions that exhibit desired pharmacological activity, along with associated therapeutic uses, providing broad protection within this chemical class.
Q2. How does the scope of this patent impact generic drug development in Japan?
The broad claims, especially if they encompass core chemical structures and key therapeutic uses, create significant barriers for generic manufacturers seeking to develop similar molecules, unless they design-around or negotiate licensing.
Q3. What are the potential challenges in patent enforcement for JP2012524724?
Challenges include overlapping prior art, potential claim interpretation difficulties, and the need for robust infringement evidence, especially given the complex patent landscape with many related patents.
Q4. Are there associated patents in other jurisdictions?
Yes, typically, applicants file similar patent families in PCT or directly in markets such as the US and EU, which collectively strengthen the patent protection strategy. These related patents often mirror the scope of JP2012524724.
Q5. How can patent landscape analysis inform drug development strategies?
It helps identify freedom-to-operate, collaboration opportunities, and potential infringement risks, guiding R&D and licensing decisions to mitigate legal uncertainties and accelerate market entry.
References
- Japan Patent JP2012524724 (full text and claims).
- International Patent Applications relating to chemical compounds and pharmaceuticals (e.g., PCT filings).
- Patent landscape reports on targeted therapies and kinase inhibitors in Japan.
